IndepenDan

Father, husband, veteran and business owner who also likes the stock market. Any stock speculation or charting is for Fun and Not Financial advice.

[IndepenDan @UseThouBrain]

@V_arrell being born on 3rd base seems better than getting out at first.

[IndepenDan @UseThouBrain]

@CapitalMattkets @HammanShares @DougKass They were bragging about it in april, not so much now

[IndepenDan @UseThouBrain]

@OTCExpert101 @ArtisTree777 Lucky you

[IndepenDan @UseThouBrain]

The judge isnt going to just say yes or no. Hes going to write his recommendation. He knows its important to be thorough no matter which way he decides. Hopefully its any day now and hes had some drafts ready to go. Ignore the noise.
$MSOS

[IndepenDan @UseThouBrain]

@CannaSzn

[IndepenDan @UseThouBrain]

@CannaSzn How does the AlJ benefit from lobbying? That makes no sense. The decision will come and the process has a better chance being held up at the next stage anyway

[IndepenDan @UseThouBrain]

@OTCExpert101 Jensen slept with an employee from each company and was converting weed companies into data centers for the ccp, even canadian companies too!

[IndepenDan @UseThouBrain]

@TradetheAction Major scam

[IndepenDan @UseThouBrain]

Goodbye “hemp”
@TheDankInformer
$MSOS

[Anthony Varrell @V_arrell]

RIP intoxicating hemp derived synthetics. 11/12/2026. $MSOS

[IndepenDan @UseThouBrain]

The big 3

$GTBIF $TRLV $CURLF $MSOS

[IndepenDan @UseThouBrain]

@Organigram_Inc Release q4 earnings before any voting please!

[IndepenDan @UseThouBrain]

@realpristinecap @lancefinlinson The canadian names are moving with msos also. Look at December. Strange

[IndepenDan @UseThouBrain]

@drjohnny__ This guy just used that innocent kid to take a picture with and sadistically dunk on Elon(the kids father) , because he spoke bad against someone celebrating a politically motivated assassination. Sick and weird , probably glammed himself up for it also.

[TDR @TheDalesReport]

James Yamanaka, CEO of @Organigram_Inc $OGI on the plan to acquire @Aurora_MMJ $ACB:

"Look, from a purely financial perspective, it is accretive. Obviously, a lot more revenue, better margin, better EBITDA, which should flow down to a better shareholder return.

It is not immediately accretive from a per share basis, but I think the exciting thing for me is really to focus on the long term future.

You bring together two strong Canadian companies. You know, you bring together the leadership in Canada in Rec and Medicine, the strong capabilities we happen to be in Moncton today, along with the EU GMP capabilities there.

Like you said, in Germany, you bring together a really strong commercial platform with the identity group with that supply, and then you know, in a medical leadership in Poland, Australia, New Zealand, and the combined regulatory culture fit that we have together.

So, to me, what a very good deal for both shareholders going forward."

🎦 WATCH the full interview: https://t.co/oopxNfOHAt

🌿 Cannabis ETFs: 🌎 $YOLO 🇺🇸 $MSOS

@FREPouch 🔥 clip

[IndepenDan @UseThouBrain]

@aaronvalue @Wheatonabix Its not just about pesticides

[IndepenDan @UseThouBrain]

@Jake__Wujastyk What the helly

[Lance Finlinson @lancefinlinson]

$MSOS Has there ever been a more bullish time with massive tail winds than now?

[IndepenDan @UseThouBrain]

@lancefinlinson Never looked better, after years of watching.

[IndepenDan @UseThouBrain]

@Shang75244162 I would assume the third party review board and a competing bid makes it different than approaching sanity seperately

[IndepenDan @UseThouBrain]

To whom it may concern,
https://t.co/gOVyRZam9j

$OGI $ACB

[IndepenDan @UseThouBrain]

https://t.co/XLYmTVvNlC